The prequotation disclosure notice contains information that is required to be provided to ASX Limited (ASX) for release to the market in connection with the admission of the official list of, and official quotation of, fully paid ordinary shares in the Company.
View the Pre-Quotation Disclosure Notice.
Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent
January 31, 2026
Imagion Biosystems Hits Major Milestone, Submits IND Application to U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent Key Highlights: Imagion Biosystems has